Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials
Elizabeth R. Volkmann, Donald P. Tashkin, Richard M. Silver, Carol Feghali Bostwick, Shervin Assassi, DeAnna Baker Frost, Mei Leng, Holly Wilhalme, Grace Hyun J. Kim, Jonathan Goldin, Michael D. Roth
Topics & Concepts
MedicinePost-hoc analysisInterstitial lung diseasePlaceboInternal medicineCyclophosphamideScleroderma (fungus)Bronchoalveolar lavageVital capacityClinical trialRandomized controlled trialPhysical therapyDiffusing capacityLungChemotherapyImmunologyPathologyLung functionInoculationAlternative medicineSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments